MiRNAs and E2F3: a complex network of reciprocal regulations in human cancers

Yanping Gao(Nanjing General Hospital of Nanjing Military Command), Rui Wang(Nanjing General Hospital of Nanjing Military Command), Longbang Chen(Nanjing General Hospital of Nanjing Military Command), Xiaoyuan Chu(Nanjing General Hospital of Nanjing Military Command), Lu Lu(University of Illinois Urbana-Champaign), Bing Feng(Guangzhou University of Chinese Medicine), Siqi Han(Chinese University of Hong Kong)
Oncotarget
April 21, 2017
10.18632/oncotarget.17364
Cited by 58

Related Papers

The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
|Nature Immunology|2021|422
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
|Nature Biotechnology|2024|258
RETRACTED ARTICLE: MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial–mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma
|Molecular Cancer|2016|151
Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
|Scientific Reports|2016|128